| Title |
ICER’s Revised Value Assessment Framework for 2017–2019: A Critique
|
|---|---|
| Published in |
PharmacoEconomics, August 2017
|
| DOI | 10.1007/s40273-017-0560-y |
| Pubmed ID | |
| Authors |
Peter J. Neumann, Joshua T. Cohen |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 23% |
| Canada | 4 | 15% |
| New Zealand | 3 | 12% |
| Australia | 2 | 8% |
| United Kingdom | 2 | 8% |
| Argentina | 1 | 4% |
| Spain | 1 | 4% |
| Germany | 1 | 4% |
| Switzerland | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 4 | 15% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 54% |
| Scientists | 8 | 31% |
| Science communicators (journalists, bloggers, editors) | 2 | 8% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 4 | 17% |
| Student > Master | 3 | 13% |
| Researcher | 3 | 13% |
| Student > Ph. D. Student | 2 | 9% |
| Professor | 2 | 9% |
| Other | 2 | 9% |
| Unknown | 7 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Economics, Econometrics and Finance | 7 | 30% |
| Medicine and Dentistry | 4 | 17% |
| Environmental Science | 1 | 4% |
| Nursing and Health Professions | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 2 | 9% |
| Unknown | 7 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2017.
All research outputs
#1,365,234
of 24,733,536 outputs
Outputs from PharmacoEconomics
#53
of 1,965 outputs
Outputs of similar age
#27,390
of 322,495 outputs
Outputs of similar age from PharmacoEconomics
#3
of 33 outputs
Altmetric has tracked 24,733,536 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,965 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.